drugset / Trial / NCT02546648

PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study

NCT02546648

RandomizedFactorialQuadruple-blindPrevention

Summary

A placebo-controlled, factorial trial to assess the impact of rosuvastatin and tranexamic acid (TXA) in patients undergoing noncardiac surgery who are at risk of a perioperative cardiovascular event.

Timeline

Start
2015-02
Primary completion
2015-10
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg Oral
Subject Tranexamic Acid Small molecule 1 g Intravenous

Indications